Search

Search Constraints

You searched for: Author/Creator Brainard, Diana M.

Search Results

1. A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection. (23rd March 2016)

3. All‐oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment‐naïve patients with genotype 1 HCV infection. Issue 1 (28th May 2014)

4. Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infection. Issue 7 (3rd April 2019)

5. Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus. Issue 1 (24th November 2014)

6. High Efficacy of Sofosbuvir/Velpatasvir Plus GS‐9857 for 12 Weeks in Treatment‐Experienced Genotype 1‐6 HCV‐Infected Patients, Including Those Previously Treated with Direct‐Acting Antivirals: 2016 ACG Presidential Poster Award: 868. (October 2016)

7. Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia. (2nd September 2017)

8. Ledipasvir‐Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C. Issue 2 (19th August 2019)

9. Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection. (29th June 2018)